Gentronix last week said it had appointed Steven Beasley as commercial director and member of the board.
Beasley will head the commercial operations of Gentronix as it moves forward with its growth plans for GreenScreen HC and its next-generation products. He was previously CEO of bioKneX and chief business officer of De Novo Pharmaceuticals.
Fluxion said last week that it has hired Steve Kushman as manufacturing director and Mark Atlas as sales director. The company also announced that Andrey Zarur, a general partner of Kodiak Venture Partners, and John Steuart, a co-founder and managing director of Claremont Creek Ventures, will join its board of directors (see story, this issue).